PREVALENCE OF HEPATITIS C VIRUS INFECTION AMONG BLOOD DONORS AT A TERTIARY CARE CENTRE: A RETROSPECTIVE STUDY

Main Article Content

Vinit Bhatnagar
Dr. Jyoti Tomar

Keywords

Hepatitis C virus, Blood donors, Seroprevalence, ELISA, Transfusion-transmitted infections

Abstract

Background: Hepatitis C virus (HCV) infection is a major transfusion-transmitted infection and a global public health challenge. Despite mandatory screening of blood donors, periodic surveillance remains essential to ensure transfusion safety.
Objectives: To determine the seroprevalence of HCV infection among blood donors at a tertiary care centre and to analyse year-wise trends.
Materials and Methods: A retrospective, record-based study was conducted in the blood bank of a tertiary care teaching hospital. Blood donor records from January 2021 to December 2025 were reviewed. All donated blood units were screened for anti-HCV antibodies using a third-generation enzyme-linked immunosorbent assay (ELISA). Data were analysed to calculate prevalence and trends.
Results: A total of 11,820 blood donations were screened during the study period. Six donors were found to be reactive for anti-HCV antibodies, yielding an overall seroprevalence of 0.05%. No reactive cases were observed in 2021 and 2023, while one reactive donor each was identified in 2022 and 2024, and four reactive donors were detected in 2025.
Conclusion:
The study demonstrates a low prevalence of HCV infection among blood donors, reflecting effective donor selection and screening practices. Continuous surveillance is necessary to maintain and improve transfusion safety.


 

Abstract 0 | PDF Downloads 0

References

1. Makroo RN, Hegde V, Chowdhry M, Bhatia A, Rosamma NL. Seroprevalence of infectious markers and their trends in blood donors in a hospital-based blood bank in North India. Indian J Med Res. 2015;142(3):317-322.
2. Pahuja S, Sharma M, Baitha B, Jain M. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in blood donors in Delhi. Asian J Transfus Sci. 2010;4(2):72-74.
3. Gupta PK, Kumar H, Basannar DR, Jaiprakash M. Transfusion transmitted infections in arWorld Health Organization. Global hepatitis report 2017. Geneva: World Health Organization; 2017.
med forces: Prevalence and trends. Med J Armed Forces India. 2006;62(4):348-350.
4. Chandra T, Kumar A, Gupta A. Prevalence of transfusion transmitted infections in blood donors: An Indian experience. Trop Doct. 2009;39(3):152-154.
5. Anand AC, Dhiman RK, Hari S, et al. Hepatitis C virus infection in India: Challenges and successes. J Clin Exp Hepatol. 2021;11(3):302-312.
6. Singh B, Verma M, Verma K. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends. Jpn J Infect Dis. 2004 Apr;57(2):49-51. PMID: 15118208.